Paper38084
The metabolism of DL-[14C]verapamil in man.
Eichelbaum M and 4 others. Drug Metab Dispos, 1979. Cited by 190 papers, by iCite.
Cite this record
ConductScience Library. The metabolism of DL-[14C]verapamil in man. Papers, record 38084. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38084
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Verapamil | Major topic |
| Aged | |
| Biotransformation | |
| Chromatography, Ion Exchange | |
| Chromatography, Thin Layer | |
| Humans | |
| Male | |
| Mass Spectrometry | |
| Middle Aged |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41786849 | Optimisation of verapamil hydrochloride loaded polyhydroxyalkanoate nano and microparticles using response surface methodology. | Sci Rep | 2026 | https://conductscience.org/library/papers/41786849 | PubMed |
| 41489333 | Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites. | J Med Chem | 2026 | https://conductscience.org/library/papers/41489333 | PubMed |
| 40250902 | Complete Heart Block Triggered by Nirmatrelvir-Ritonavir and Verapamil. | JACC Case Rep | 2025 | https://conductscience.org/library/papers/40250902 | PubMed |
| 40244664 | Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40244664 | PubMed |
| 32560124 | A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug-Drug Interaction Studies. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32560124 | PubMed |
| 27471437 | Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation. | Metabolomics | 2016 | https://conductscience.org/library/papers/27471437 | PubMed |
| 25237334 | Metabolite parameters as an appropriate alternative approach for assessment of bioequivalence of two verapamil formulations. | Iran J Pharm Res | 2014 | https://conductscience.org/library/papers/25237334 | PubMed |
| 24773296 | Zebrafish as model organisms for studying drug-induced liver injury. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24773296 | PubMed |
| 22351295 | MS(M), an efficient workflow for metabolite identification using hybrid linear ion trap Orbitrap mass spectrometer. | J Am Soc Mass Spectrom | 2012 | https://conductscience.org/library/papers/22351295 | PubMed |
| 20166433 | Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats. | Eur J Drug Metab Pharmacokinet | 2009 | https://conductscience.org/library/papers/20166433 | PubMed |
| 20012601 | Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20012601 | PubMed |
| 19774562 | A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. | Chemistry | 2009 | https://conductscience.org/library/papers/19774562 | PubMed |
| 19026953 | Rapid solid-phase extraction method to quantify [(11)C]-verapamil, and its [(11)C]-metabolites, in human and macaque plasma. | Nucl Med Biol | 2008 | https://conductscience.org/library/papers/19026953 | PubMed |
| 18193210 | Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18193210 | PubMed |
| 17846766 | Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients. | Eur J Nucl Med Mol Imaging | 2008 | https://conductscience.org/library/papers/17846766 | PubMed |
| 16250259 | Influence of famotidine on verapamil pharmacokinetics in rats. | Eur J Drug Metab Pharmacokinet | 2005 | https://conductscience.org/library/papers/16250259 | PubMed |
| 15128524 | Transformation of verapamil by Cunninghamella blakesleeana. | Appl Environ Microbiol | 2004 | https://conductscience.org/library/papers/15128524 | PubMed |
| 14999438 | Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo. | Naunyn Schmiedebergs Arch Pharmacol | 2004 | https://conductscience.org/library/papers/14999438 | PubMed |
| 11136300 | Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. | Br J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/11136300 | PubMed |
| 10336579 | Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10336579 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38084
GET https://conductscience.org/api/papers/v1/38084/cited_by?page=2